Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Mar 14;37(8):1574–1586. doi: 10.1097/HJH.0000000000002088

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc.

This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0

PMC Copyright notice

Results of recent meta-analyses that compare therapeutic classes. Results of recent meta-analyses that compare the effect of diuretics on selected clinical endpoints with that of other therapeutic classes [16–20]. (a) Stroke and heart failure. (b) Cardiovascular and all-cause mortality. ^∗Not explicitly defined. ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker; CI, confidence interval; HTN, hypertension; HR, hazard ratio; LD, low dose; ND, no data in publication; PL, placebo; RASI, renin–angiotensin system inhibitor; RR, relative risk; T2D, type 2 diabetes mellitus; TL, thiazide-like diuretic; TZ, thiazide diuretic.